Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1381612822999160321124803 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: Neutrophil heterogeneity in healing and tissue damage.
Front Immunol
December 2024
Department of Biomedical Engineering, University of Memphis, Memphis, TN, United States.
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.
Front Oncol
December 2024
Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Introduction: Lung cancer is the first cause of cancer death in the world, due to a delayed diagnosis and the absence of efficacy therapies. KRAS mutation occurs in 25% of all lung cancers and the concomitant mutations in LKB1 determine aggressive subtypes of these tumors. The improvement of therapeutical options for KRASG12C mutations has increased the possibility of treating these tumors, but resistance to these therapies has emerged.
View Article and Find Full Text PDFTesting and cancer diagnosis in general practice.
BMJ Qual Saf
January 2025
Centre for Academic Primary Care, University of Bristol, Bristol, UK
Mechanical power and VILI: modeling limits and unknowns.
Intensive Care Med Exp
January 2025
Department of Pulmonary and Critical Care Medicine, University of Minnesota, St Paul, Minneapolis, MN, USA.
Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into pathogenesis.
Front Cell Infect Microbiol
January 2025
Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, UTHealth-McGovern Medical School, Houston, TX, United States.
Interstitial lung disease (ILD) is characterized by chronic inflammation and scarring of the lungs, of which idiopathic pulmonary fibrosis (IPF) is the most devastating pathologic form. Idiopathic pulmonary fibrosis pathogenesis leads to loss of lung function and eventual death in 50% of patients, making it the leading cause of ILD-associated mortality worldwide. Persistent and subclinical microbial infections are implicated in the acute exacerbation of chronic lung diseases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!